Clinical Trial Update: Oral Versus Intravenous Hydration to Prevent Contrast Induced Nephropathy [Phase 4]

View source ↗

Summary

Phase 4 trial comparing oral versus intravenous hydration to prevent contrast-induced nephropathy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy

Snippet

Sponsor: The Western Pennsylvania Hospital | Conditions: Contrast Induced Nephropathy | Phase 4 | Status: WITHDRAWN